Your browser doesn't support javascript.
loading
Need for caution when interpreting Xpert® MTB/RIF results for rifampin resistance among children.
Murithi, W; Click, E S; McCarthy, K D; Okeyo, E; Sitati, R; Anyango, I; Okumu, A; Mchembere, W; Song, R; Cain, K.
Afiliação
  • Murithi W; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Click ES; U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA USA.
  • McCarthy KD; CDC, Kisumu, Kenya.
  • Okeyo E; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Sitati R; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Anyango I; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Okumu A; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Mchembere W; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Song R; Division of Infectious Diseases, Boston Children´s Hospital, Boston, MA, Department of Pediatrics, Harvard Medical School, Boston, MA, USA, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Cain K; CDC, Kisumu, Kenya.
Int J Tuberc Lung Dis ; 25(11): 911-916, 2021 11 01.
Article em En | MEDLINE | ID: mdl-34686233

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Antibióticos Antituberculose / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Antibióticos Antituberculose / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article